Medicare Part D by State
Medicare Part D is the drug benefit for about 50 million older and disabled Americans. CMS publishes how many prescriptions doctors in each state wrote for each drug. This compares states: what they spend, how much of it is opioids or antibiotics, and which drug each state uses unusually often.
What Medicare's drug plans paid for prescriptions in each state in 2024, the share of claims that were opioids, antibiotics and antipsychotics, and the drug each state uses most out of line with the rest of the country.
- Part D drug cost, 2024: $288.0B
- Opioid share of claims, 2024: 3.5%
- Peak, 2014: 5.9%
- Highest opioid share: Alabama, 5.2%
- Lowest: Puerto Rico, 0.6%
Opioid Share of Part D Claims
National, 2013 to 2024.
Highest Opioid Share
Share of each state's Part D claims, 2024.
- Alabama5.2%
- Utah5.1%
- Idaho5%
- Oklahoma4.8%
- Arkansas4.7%
- Oregon4.7%
- Colorado4.7%
- Nevada4.7%
- Wyoming4.6%
- Kentucky4.5%
Highest Antibiotic Share
Share of each state's Part D claims, 2024.
- Florida5.2%
- Texas5%
- Arizona5%
- Nevada4.9%
- Alabama4.8%
- Hawaii4.8%
- Mississippi4.7%
- Utah4.7%
- West Virginia4.7%
- Virginia4.6%
Every State
Sorted by opioid share. A drug's rate is its share of the state's claims against its share nationally.| Most distinctive drug | |||||||
|---|---|---|---|---|---|---|---|
| Alabama | $5.3B | 32.5M | $165 | 5.2% | 4.8% | 1.6% | Levocetirizine Dihydrochloride2.7× the national rate |
| Utah | $1.6B | 10.4M | $158 | 5.1% | 4.7% | 1.9% | Liothyronine Sodium4.0× the national rate |
| Idaho | $1.3B | 8.4M | $156 | 5.0% | 4.1% | 2.1% | Thyroid,pork3.1× the national rate |
| Oklahoma | $3.3B | 20.9M | $158 | 4.8% | 4.5% | 1.6% | Buprenorphine Hcl3.4× the national rate |
| Arkansas | $2.7B | 20.5M | $132 | 4.7% | 4.3% | 1.5% | Propafenone Hcl3.2× the national rate |
| Oregon | $3.0B | 19.3M | $157 | 4.7% | 3.8% | 1.9% | Fluoride (Sodium)4.4× the national rate |
| Colorado | $3.7B | 20.4M | $182 | 4.7% | 4.5% | 1.7% | Dabigatran Etexilate Mesylate4.0× the national rate |
| Nevada | $2.0B | 11.8M | $173 | 4.7% | 4.9% | 1.5% | Trihexyphenidyl Hcl2.4× the national rate |
| Wyoming | $259M | 2.1M | $121 | 4.6% | 4.5% | 1.6% | Liothyronine Sodium2.4× the national rate |
| Kentucky | $5.0B | 33.2M | $150 | 4.5% | 4.4% | 1.5% | Promethazine Hcl3.1× the national rate |
| Tennessee | $7.1B | 44.4M | $161 | 4.4% | 4.6% | 1.6% | Promethazine Hcl2.9× the national rate |
| Montana | $704M | 5.3M | $134 | 4.4% | 3.8% | 2.0% | Sodium Chloride/Nahco3/Kcl/Peg2.7× the national rate |
| Georgia | $9.1B | 54.0M | $169 | 4.3% | 4.3% | 1.6% | Cyproheptadine Hcl2.8× the national rate |
| Washington | $4.8B | 30.0M | $161 | 4.3% | 3.8% | 2.1% | Ciclesonide3.9× the national rate |
| Indiana | $6.5B | 40.0M | $162 | 4.3% | 4.4% | 1.6% | Galantamine Hbr2.4× the national rate |
| Michigan | $9.8B | 57.9M | $170 | 4.2% | 4.4% | 2.0% | Sodium Chloride/Nahco3/Kcl/Peg2.2× the national rate |
| Louisiana | $4.8B | 30.2M | $159 | 4.2% | 4.2% | 1.7% | Cyproheptadine Hcl5.8× the national rate |
| North Carolina | $10.2B | 60.5M | $169 | 4.2% | 4.3% | 1.5% | Oxycodone Myristate3.0× the national rate |
| Kansas | $2.4B | 16.4M | $143 | 4.1% | 4.3% | 1.9% | Pen Needle,dual Safety,diabetc2.2× the national rate |
| Mississippi | $2.7B | 19.0M | $143 | 4.1% | 4.7% | 1.7% | Cyproheptadine Hcl5.6× the national rate |
| Arizona | $5.4B | 30.4M | $176 | 4.1% | 5.0% | 1.7% | Liothyronine Sodium2.5× the national rate |
| South Carolina | $5.2B | 30.3M | $173 | 4.0% | 4.6% | 1.4% | Colesevelam Hcl2.1× the national rate |
| Missouri | $6.0B | 39.8M | $151 | 3.9% | 4.0% | 2.0% | Paliperidone2.1× the national rate |
| Alaska | $396M | 1.9M | $206 | 3.9% | 3.9% | 2.6% | Thyroid,pork5.3× the national rate |
| New Mexico | $1.3B | 8.3M | $152 | 3.9% | 4.5% | 1.5% | Thyroid,pork3.2× the national rate |
| Maryland | $4.5B | 23.7M | $191 | 3.8% | 4.5% | 2.1% | Oxycodone Hcl2.3× the national rate |
| Delaware | $941M | 5.2M | $180 | 3.7% | 4.4% | 1.7% | Oxycodone Myristate2.7× the national rate |
| Texas | $20.1B | 114.7M | $175 | 3.6% | 5.0% | 1.3% | Acetaminophen With Codeine3.7× the national rate |
| Florida | $21.5B | 130.3M | $165 | 3.5% | 5.2% | 1.5% | Sildenafil Citrate3.4× the national rate |
| South Dakota | $699M | 4.9M | $141 | 3.5% | 4.3% | 1.8% | Sodium Chloride/Nahco3/Kcl/Peg4.2× the national rate |
| Nebraska | $1.6B | 10.9M | $146 | 3.4% | 4.1% | 2.0% | Diphth,pertuss(Acell),tet Vac4.7× the national rate |
| California | $27.3B | 152.0M | $180 | 3.3% | 4.4% | 1.7% | Ciclesonide6.7× the national rate |
| Virginia | $6.1B | 37.5M | $163 | 3.3% | 4.6% | 1.7% | Hydromorphone Hcl1.6× the national rate |
| Maine | $1.4B | 8.0M | $179 | 3.3% | 4.1% | 2.1% | Lisdexamfetamine Dimesylate5.0× the national rate |
| Wisconsin | $4.9B | 31.7M | $154 | 3.3% | 3.8% | 2.0% | Lisdexamfetamine Dimesylate3.0× the national rate |
| Ohio | $11.3B | 71.2M | $159 | 3.3% | 4.5% | 1.9% | Dofetilide2.1× the national rate |
| Vermont | $541M | 3.1M | $175 | 3.2% | 4.1% | 2.2% | Methylphenidate Hcl4.8× the national rate |
| West Virginia | $1.9B | 12.9M | $145 | 3.2% | 4.7% | 1.6% | Buprenorphine Hcl/Naloxone Hcl3.5× the national rate |
| Iowa | $2.4B | 18.7M | $130 | 3.2% | 4.1% | 2.0% | Warfarin Sodium2.4× the national rate |
| Illinois | $9.6B | 60.0M | $161 | 3.2% | 4.4% | 1.8% | Hepatitis A And B Vaccine/Pf3.6× the national rate |
| Minnesota | $4.3B | 27.3M | $158 | 3.1% | 4.1% | 2.3% | Mometasone/Formoterol3.0× the national rate |
| New Hampshire | $1.1B | 7.0M | $164 | 3.0% | 4.4% | 2.3% | Buprenorphine Hcl3.4× the national rate |
| North Dakota | $549M | 4.4M | $125 | 3.0% | 3.9% | 1.8% | Pen Needle,dual Safety,diabetc4.2× the national rate |
| Pennsylvania | $14.0B | 83.5M | $168 | 2.9% | 4.2% | 1.8% | Repaglinide3.1× the national rate |
| Connecticut | $4.1B | 20.0M | $205 | 2.8% | 4.2% | 2.2% | Fluoride (Sodium)3.1× the national rate |
| Hawaii | $997M | 4.6M | $216 | 2.8% | 4.8% | 1.5% | Denosumab8.9× the national rate |
| Massachusetts | $7.6B | 38.3M | $199 | 2.7% | 4.0% | 2.4% | Cefpodoxime Proxetil4.9× the national rate |
| District of Columbia | $716M | 2.5M | $287 | 2.7% | 4.2% | 2.1% | Bictegrav/Emtricit/Tenofov Ala7.8× the national rate |
| Rhode Island | $953M | 6.5M | $146 | 2.4% | 4.0% | 2.4% | Ramelteon2.8× the national rate |
| New Jersey | $8.0B | 42.0M | $191 | 2.4% | 4.6% | 1.8% | Repaglinide5.3× the national rate |
| New York | $22.9B | 110.8M | $207 | 2.1% | 4.2% | 1.9% | Ammonium Lactate4.8× the national rate |
| Puerto Rico | $3.1B | 30.9M | $99 | 0.6% | 2.9% | 1.6% | Diclofenac Potassium20.7× the national rate |
By the state of the prescriber, not the patient. Costs are what plans, patients and Medicare paid at the pharmacy, before manufacturer rebates. Opioid, antibiotic and antipsychotic are CMS's own drug flags. The most distinctive drug is the one with the highest rate against the national rate, among drugs with at least 200,000 claims nationally and 2,000 in the state. CMS releases each year about 18 months after it ends. Refreshed weekly. CMS, Medicare Part D Prescribers by Geography and Drug